MAYINGLONG HEMORRHOIDS- zinc oxide suppository

Mayinglong Hemorrhoids by

Drug Labeling and Warnings

Mayinglong Hemorrhoids by is a Otc medication manufactured, distributed, or labeled by Mayinglong Pharmaceutical Group Co., Ltd. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active Ingredients

Zinc Oxide   57.2%

Purpose

Zinc Oxide      Astrigent

Uses

To reduce fever and toxic materials, subduces swelling, and relieve from pain. To stop bleeding and promote tissue regeneration. For internal and external hemorrhoids.

Warning

Not for oral use.

Immerse it into cool water if it has softened during high temperature.

Eat more vegetables and fruits, avoid constipation, restrict cigarettes, wine and spicy foods.

Warning

Keep out of reach of children.

Warning

Apply it carefully during pregancy or as directed by a physician.

Directions

Insert one suppository into anus, twice a day or as directed by a physician.

Storage

Store tightly closed in a cool place.

Inactive Ingredients

Musk Ketone, Hyriopsis Cumingii Whole, Borneol, Panax Rotoginseng Root, Belladonna Leaf, Rhus Chinensis Whole, Diacetyltartaric and Fatty Acid Esters of Glycerol

Drug Facts

INGREDIENTS AND APPEARANCE

MAYINGLONG HEMORRHOIDS 
zinc oxide suppository

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 68511-350
Route of Administration	RECTAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z)	ZINC OXIDE	1.7 g

Inactive Ingredients
Ingredient Name	Strength
MUSK KETONE (UNII: 483V3E1L6J)
HYRIOPSIS CUMINGII WHOLE (UNII: 8VRP283387)
BORNEOL (UNII: M89NIB437X)
PANAX NOTOGINSENG ROOT (UNII: GQX1C1175U)
BELLADONNA LEAF (UNII: 6GZW20TIOI)
RHUS CHINENSIS WHOLE (UNII: J6BED8187F)
DIACETYLTARTARIC AND FATTY ACID ESTERS OF GLYCEROL (UNII: 248HN3Z28U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 68511-350-86	6 in 1 BOX
1	NDC: 68511-350-82	1 in 1 BLISTER PACK

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part346	07/15/2009

Labeler - Mayinglong Pharmaceutical Group Co., Ltd (526823828)

Registrant - Mayinglong Pharmaceutical Group Co., Ltd (526823828)

Establishment
Name	Address	ID/FEI	Business Operations
Mayinglong Pharmaceutical Group Co., Ltd		526823828	manufacture(68511-350)